Transforming Parkinson's Disease Treatment

Parkinson's disease

Parkinson's Disease is the fastest growing neurodegenerative disease. Over 60,000 patients a year are diagnosed with Parkinson’s disease. It causes 30,000 deaths each year. In the US over 1 million patients are living with the disease.

Current THERAPIES

Current therapies restore motor function, but all patients will suffer neuron death and advance in the disease.

Let's stop PD in its tracks

Our Mission

Our mission is to stop cognitive decline and improve motor function in Parkinson's Disease patients.

Our Technology

URMC-099

URMC-099 is a novel anti-inflammatory compound targeting a known cellular pathway.

Approach

Works by 'right-sizing' immune response to keep inflammation in check while preventing neuron cell death.

Mechanism

By inhibiting MLK3

and LRRK2, URMC-099 reverses neuroinflammation and prevents

neuron death.

Our ultimate Goal:

To improve the quality of life after a Parkinson's diagnosis.

Our Team

Website by: yda